Regorafenib in Pediatric Patients With Advanced Osteosarcoma: A Case Series from a Single Institution
Anticancer Research · 2026-08 · 46 (8) · 4591-4598
DOI: 10.21873/anticanres.18315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Yumi Matsuyama und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu, Japan. Hauptthemen laut MEDLINE: Phenylurea Compounds, Pyridines, Osteosarcoma, Bone Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu, Japan.
- Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu, Japan; kasanum@gmail.com.
- Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
Zitieren
APA
Matsuyama, Y., Asanuma, K., Hagi, T., Nakamura, T., Hanaki, R., Toyoda, H., Hirayama, M., & Hasegawa, M. (2026). Regorafenib in Pediatric Patients With Advanced Osteosarcoma: A Case Series from a Single Institution. Anticancer Research, 46(8), 4591-4598. https://doi.org/10.21873/anticanres.18315
Vancouver
Matsuyama Y, Asanuma K, Hagi T, Nakamura T, Hanaki R, Toyoda H, et al. Regorafenib in Pediatric Patients With Advanced Osteosarcoma: A Case Series from a Single Institution. Anticancer Research. 2026;46(8):4591-4598. doi:10.21873/anticanres.18315
BibTeX
@article{Matsuyama2026,
author = {Matsuyama, Yumi and Asanuma, Kunihiro and Hagi, Tomohito and Nakamura, Tomoki and Hanaki, Ryo and Toyoda, Hidemi and Hirayama, Masahiro and Hasegawa, Masahiro},
title = {Regorafenib in Pediatric Patients With Advanced Osteosarcoma: A Case Series from a Single Institution},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {8},
pages = {4591--4598},
doi = {10.21873/anticanres.18315}
}
EUVIMED